Name: Drug Compounding. Background, Issues & FDA Oversight
SKU: 64756007
Price: 2944.00 ZAR
Availability: InStock
Author: Martti Bram
ISBN: 9781631173608

Select your country

Americas

Europe

Rest of the world

portada Drug Compounding. Background, Issues & FDA Oversight

Drug Compounding. Background, Issues & FDA Oversight

Type

Physical Book

Publisher

Nova Science Publishers

Author

Martti Bram

Year

2014

Pages

123

Format

Hardcover

Dimensions

23.8x15.7x1.5 cm

ISBN13

9781631173608

Drug Compounding. Background, Issues & FDA Oversight

Martti Bram (Author) · Nova Science Publishers · Hardcover

New Book Imported to South Africa

Delivery: 15 Oct - 23 Oct

R 2,944

R 2,944

Add to Wishlist

Synopsis "Drug Compounding. Background, Issues & FDA Oversight"

Compounding has been traditionally defined as a process where a pharmacist or a physician combines, mixes, or alters ingredients to create a medication tailored to the needs of an individual patient. Traditionally compounded drugs (CDs) are made in response to an individual prescription from a licensed health provider in the context of a pharmacist''s and health care professional''s relationship with a specific patient. This book provides background information on CDs and non-traditional compounding pharmacies relevant to policy discussions. This book will also examine the FDA''s regulation of drug compounding and will discuss relevant legal authorities. Specifically, the status of FDA''s authority to oversee drug compounding, and the gaps, if any, between state and federal authority will be discussed, as well as how FDA has used its data and authority to oversee drug compounding, and the actions taken or planned by states or national pharmacy organisations to improve oversight of drug compounding.